FFFMX | SVAIX | FFFMX / SVAIX | |
Total Expense Ratio | 0.32 | 0.81 | 40% |
Annual Report Gross Expense Ratio | 0.32 | 0.93 | 34% |
Fund Existence | 5 years | 21 years | - |
Gain YTD | 14.204 | 12.062 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 111B | 8.67B | 1,280% |
Annual Yield % from dividends | 1.72 | 3.20 | 54% |
Returns for 1 year | 5.60 | 4.94 | 113% |
Returns for 3 years | 41.37 | 29.78 | 139% |
Returns for 5 years | N/A | 66.29 | - |
Returns for 10 years | N/A | 45.95 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 75.17 | 0.46 | +0.62% |
Janus Henderson Global Life Sciences T | |||
GSMVX | 16.78 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity Instl | |||
RAMHX | 38.79 | 0.04 | +0.10% |
American Funds American Balanced R2E | |||
SGQCX | 42.96 | -0.03 | -0.07% |
DWS International Growth C | |||
TIISX | 13.84 | -0.09 | -0.65% |
Nuveen Quant Intl Small Cap Eq R6 |